Drug news
CE Mark for Vivia Hemodialysis System-Baxter
Baxter International Inc. announced completion of CE marking in Europe for the Vivia Hemodialysis (HD) System, designed to deliver more frequent, extended duration, short daily or nocturnal home HD therapy, known as High Dose HD therapy.
Baxter said it envisions a launch of its Vivia Hemodialysis System to a select number of European dialysis clinics starting in 2014, to help patients and providers learn the technology. A larger European launch will follow in 2015.
The concept of a home-use device is also a advantage considering that haemodialysis is typically administered at a clinic or dialysis centre a few days a week and can take several hours to complete.